Condition
EGFR-TKI Resistant Mutation clinical trials and research
As of November 12, 2026, Find a Trial lists 4 EGFR-TKI Resistant Mutation clinical trials that are recruiting, at sites in 2 countries (most in China (3), Taiwan (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest EGFR-TKI Resistant Mutation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining osimertinib and dalpiciclib for advanced lung cancer after treatment resistance | Phase 2 | Tianjin, Tianjin Municipality | Recruiting | Apr 12, 2024 |
| Combining Nintedanib with EGFR inhibitors for advanced lung cancer | Phase 1/2 | Taichung | Recruiting | Oct 6, 2023 |
| Understanding why some lung cancer patients don't respond to new treatments | — | Changsha, Hunan | Recruiting | Oct 28, 2022 |
| Evaluating EGFR-TKI treatments in lung cancer patients | — | Guangzhou, Guangdong | Recruiting | Nov 25, 2013 |
All recruiting trials (4)
-
Combining osimertinib and dalpiciclib for advanced lung cancer after treatment resistance
This study is testing if combining two drugs, osimertinib and dalpiciclib, can help people with advanced lung cancer who have not responded to other treatments.
-
Combining Nintedanib with EGFR inhibitors for advanced lung cancer
This study is testing if combining a medication called Nintedanib with EGFR inhibitors can help people with advanced lung cancer who haven't responded to previous treatments.
-
Understanding why some lung cancer patients don't respond to new treatments
This study is trying to understand why some patients with advanced lung cancer don't respond to new treatments so that doctors can better tailor therapies to help them.
-
Evaluating EGFR-TKI treatments in lung cancer patients
This study is testing how well different EGFR-TKI treatments work for people with advanced lung cancer and looking at how genetic factors and drug levels affect their results.
Related topics
Quick answers
How many EGFR-TKI Resistant Mutation clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.